Journals / MN Kardiyoloji / 2019 / Cilt: 26 - Sayı: 1

Uncontrolled Type 2 Diabetes Increase Masked Hypertension

Kontrolsüz Tip 2 Diyabet Maskeli Hipertansiyon Sıklığını Artırıyor

Pages
38–44
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Uncontrolled diabetic patients might have tight blood pressure monitoring.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: An increased prevalence of high blood pressure levels has been demonstrated among patients with diabetes mellitus.
📊
Key Findings & Data:The aim of this study was to determine the prevalence of masked hypertension in diabetic patients and evaluate the relationship between HbA1c and masked hypertension.
💡
Conclusion & Impact:Uncontrolled diabetic patients might have tight blood pressure monitoring.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: An increased prevalence of high blood pressure levels has been demonstrated among patients with diabetes mellitus. The aim of this study was to determine the prevalence of masked hypertension in diabetic patients and evaluate the relationship between HbA1c and masked hypertension. Material and Method: This study included Type 2 diabetic patients (n=72) with normal office blood pressure. Masked hypertension was defined as an office blood pressure < 140/90 mmHg and mean ambulatory blood pressure ≥130/80 mmHg. Results: Masked hypertension was detected in 41.6% of 72 diabetic patients based on established criteria. The serum HbA1c levels were significantly higher in masked hypertension group than normotensive group (7.6 ± 1.9 vs 6.7 ± 1.3 respectively, p=0.037). Conclusion: Patients with higher HbA1c levels had increased blood pressure measurements in ambulatory blood pressure monitoring. Uncontrolled diabetic patients might have tight blood pressure monitoring.

Özet

Amaç: Diyabet ile takipli hastalarda kan basıncı yüksekliği ve buna bağlı organ hasarları sık görülmektedir. Bu çalışmada diyabet ile takipli hastalarda maskeli hipertansiyon sıklığını ve HbA1c düzeyleri ile maskeli hipertansiyon arasındaki ilişkiyi değerlendirmeyi amaçladık. Gereç ve Yöntem: Çalışmamıza poliklinikte ölçülen kan basıncı normal olup Tip 2 diyabet (n=72) ile takipli olan hastalar dahil edildi. Maskeli hipertansiyon; poliklinik kan basıncı <140/90 mmHg ve ambulatuvar kan basıncı monitörizasyonuna göre ortalama kan basıncı ≥130/80 mmHg olması olarak tanımlandı. Bulgular: 72 diyabetik hastanın %41,6’sında belirtilen kriterlere göre maskeli hipertansiyon tespit edildi. HbA1c düzeyleri maskeli hiper- tansiyon grubunda, normal kan basıncına sahip kişilere göre anlamlı olarak yüksek bulundu (7,6 ± 1,9 ve 6,7 ± 1,3 sırasıyla, p=0,037). Sonuç: HbA1c seviyesi yüksek olan hastalar ambulatuvar kan basıncı monitörizasyonuna göre daha yüksek kan basıncına sahipler. Dolayısıyla kontrolsüz diyabeti olan hastalarda daha sıkı kan basıncı takibi gerekmektedir.

🔖

Cite This Article

YAMAN, B., AÇIKGÖZ, E., AÇIKGÖZ, S. K., ÇENGEL, A. (2019). Uncontrolled Type 2 Diabetes Increase Masked Hypertension. MN Kardiyoloji, Cilt: 26 - Sayı: 1, 38–44. https://ajindex.com/articles/297205

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of world- wide data. Lancet 2005;365(9455):217-23.
  2. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988- 1994 and 1999-2004. Hypertension 2008;52(5):818-27.
  3. Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hy- pertension. Hypertension 2002;40(6):795-6.
  4. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hyperten- sion of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens 2018 Oct;36(10):1953-2041.
  5. Bobrie G, Clerson P, Menard J, Postel-Vinay N, Chatellier G, Plouin PF. Masked hypertension: a systematic review. J Hypertens 2008;26:1715-25.
  6. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long- term risk of mortality associated with selective and com- bined elevation in office, home, and ambulatory blood pressure. Hypertension 2006;47:846-53
  7. Fagard RH, Cornelissen VA.Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens 2007;25:2193-8.
  8. LurbeE, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, Batlle D. Increase in nocturnal blood pressure and progres- sion to microalbuminuria in type 1 diabete. New Engl J Med 2002;347:797-805.
  9. Mancia G, Bombelli M, Facchetti R, et al. Long-term risk of sustained hypertension in white-coat or masked hyperten- sion. Hypertension. 2009;54(2):226-32.
  10. Bobrie G, Chatellier G, Genes N, et al. Cardiovascular prog- nosis of "masked hypertension" detected by blood pres- sure self-measurement in elderly treated hypertensive pa- tients. Jama. 2004;291(11):1342-9.
  11. Mallion JM, Clerson P, Bobrie G, Genes N, Vaisse B, Chatellier G. Predictive factors for masked hypertension within a population of controlled hypertensives. Journal of hypertension 2006;24(12):2365-70.
  12. Andalib A, Akhtari S, Rigal R, et al. Determinants of masked hypertension in hypertensive patients treated in a primary care setting. Internal medicine journal 2012;42(3):260-6. Pickering TG. The natural history of hypertension: prehy- pertension or masked hypertension? Journal of clinica